Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead’s Lander Joins Aclara BioSciences Board

Premium

M

OUNTAIN VIEW, Calif.--Aclara BioSciences announced that Eric Lander has joined its board of directors. Lander is director of the Whitehead/MIT Center for Genome Research, a member of the Whitehead Institute for Biomedical Research, and a founder and director of Millennium Pharmaceuticals.

"Aclara’s technology can dramatically accelerate numerous areas of genomics research," said Lander. He noted that the company "has put in place the business relationships to enable it to take advantage of these opportunities." Joseph Limber, Aclara’s president and CEO, said Lander’s "knowledge, experience, and insights will be extremely valuable as we develop our microfluidics technology for a broad range of genomics applications." Aclara uses a proprietary microfluidic lab-on-a-chip technology to create new tools for genomics and pharmaceutical drug screening.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.